Emotional blunting with antidepressant treatments: A survey among depressed patients

Journal of Affective Disorders

Volumn 221, Issue , 2017, Pages 31-35

  Goodwin, G M ^a   Price, J ^a   De Bodinat, C ^b   Laredo, J ^b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Anhedonia; Antidepressant; Apathy; Depression; Emotional blunting; Internet survey; Oxford Questionnaire on the Emotional Side Effects of Antidepressants, OQESA; Selective Serotonin Reuptake Inhibitor; SSRI

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESVENLAFAXINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTIONAL BLUNTING; EMOTIONALITY; FEMALE; HEALTH SURVEY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; CASE CONTROL STUDY; CHEMICALLY INDUCED; EMOTION; EMOTIONAL DISORDER; PSYCHOLOGY; YOUNG ADULT;

ADULT; AFFECTIVE SYMPTOMS; ANTIDEPRESSIVE AGENTS; BUPROPION; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85020873752     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.05.048     Document Type: Article

References (10)

1. Bjelland, I., Dahl, A.A., Haug, T.T., Neckelmann, D., The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J. Psychosom. Res. 52 (2002), 69–77.
2. Blier, P., Briley, M., The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatr. Dis. Treat. 7 (2011), 15–20.
3. Bolling, M.Y., Kohlenberg, R.J., Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother. Psychosom. 73 (2004), 380–385.
4. Dargél, A.A., Godin, O., Etain, B., Hirakata, V., Azorin, J.M., M'Bailara, K., Bellivier, F., Bougerol, T., Kahn, J.P., Passerieux, C., Aubin, V., Emotional reactivity, functioning, and C-reactive protein alterations in remitted bipolar patients: clinical relevance of a dimensional approach. Aust. N. Z. J. Psychiatry, 2017 (Apr 1:0004867417691850).
5. Fava, M., Graves, L.M., Benazzi, F., Scalia, M.J., et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J. Clin. Psychiatry 67 (2006), 1754–1759.
6. McCabe, C., Cowen, P.J., Harmer, C.J., Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) 205 (2009), 667–677.
7. Opbroek, A., Delgado, P.L., Laukes, C., McGahuey, C., et al. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?. Int. J. Neuropsychopharmacol. 5 (2002), 147–151.
8. Price, J., Cole, V., Doll, H., Goodwin, G.M., The Oxford Questionnaire on the Emotional Side-Effects of Antidepressants: development validity, reliability and sensitivity to change. J. Affect. Disord. 140 (2012), 66–74.
9. Price, J., Cole, V., Goodwin, G.M., Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br. J. Psychiatry 195 (2009), 211–217.
10. Sansone, R.A., Sansone, L.A., SSRI-induced indifference. Psychiatry (Edgmont) 7 (2010), 14–18.